Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Chiral Technologies
Chiral Technologies
Activities:
Manufacturing
Research & Development
Analysis
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Memel Biotech and Therabest collaborate to develop exosome-based cell therapies
The partnership will aim to develop, manufacture and distribute novel exosome cell therapies in a range of therapeutic areas
Ipsen and Skyhawk Therapeutics partner to develop RNA-targeting drug candidates
The USD $1.8bn deal will support the development of novel RNA-modulating drugs using Skyhawk's proprietary technology
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Manufacturing
Chiral Technologies promotes Joseph Barendt to President
For the past decade he has been Chief Operating Officer at the enantioselective chromatography specialist
Manufacturing
Chiral Technologies buys Diffinity Genomics
Diffinity Genomics has developed novel technology for the purification of nucleic acids
Manufacturing
Chiral Technologies introduces Chiralflash liquid chromatography columns
MPLC columns are packed with immobilised chiral stationary phases
Analysis
Chiral Technologies introduces technology for separating free amino acids
Chiralpak Zwix (+) and Chiralpak Zwix (-) exhibit stereoselectivity for zwitterionic molecules
Chiral Technologies introduces chiral stationary phase
Chiralpak ID is the fourth addition to the family
Manufacturing
Chiral Technologies gains rights to CSPs
Signs exclusive agreement with University of Vienna
Subscribe now